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Abstract The role of thiols as oxidant scavengers during 
inactivation of bovine glucose-6-phosphate dehydrogenase by 
metal-catalyzed oxidation systems has been studied in vitro. 
Partial inactivation of the enzyme was achieved by the metal- 
catalyzed oxidation systems Fe(II)IH2021EDTA or Fe(ll)l 
H2021ADP under specific conditions. When EDTA as chelator 
~as present in the oxidation system, both cysteine and N- 
aeetylcysteine at low concentrations (0.I- I  mM) drastically 
enhanced inactivation, while cysteinyl-glycine and glutathione 
did not. The thiol-mediated inactivation was inhibitable by 
superoxide dismutase. Depletion of enzyme activity by cysteine 
~as paralleled by an increase of the carbonyl content, which 
indicates oxidative injury. However, when EDTA as chelator was 
replaced by the natural chelator ADP, all thiols studied acted as 
aatioxidants. It is therefore concluded that the nature of the 
chelator as a constituent of the metal-catalyzed oxidation 
systems determines whether the antioxidative function of some 
thiols is shifted to a prooxidative function against glucose-6- 
phosphate dehydrogenase. 
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iological conditions, free Fe(II) or Fe(IIl) ions occur at ex- 
tremely low concentrations i  tissues or organs, since they are 
bound to ferritin, transferrin or lactoferrin, thus being not 
available for metal-catalyzed oxidation (MCO) systems. How- 
ever, at inflamed sites, iron ions might be mobilized from the 
stores by oxidative [12-15] or proteolytic mechanisms [16], 
thus increasing the risk of oxidative damage by hydroxyl rad- 
icals generated via Fenton-like systems. In context with the 
therapeutic administration f thiols, e.g. in inflammatory lung 
diseases howing strong GSH depletion, we asked the ques- 
tion whether thiols at local conditions might enhance oxida- 
tive damage of relevant enzymes or proteins by MCO systems, 
instead of protecting them from reactive oxygen metabolites. 
In an in vitro approach, we studied the effect of several thiols 
on the metal-catalyzed oxidation of mammalian glucose-6- 
phosphate dehydrogenase (GPDH), a target enzyme being 
sensitive to oxidative stress [17,18]. We found that both cys- 
teine (CYS) and NAC drastically enhanced inactivation of the 
enzyme by an EDTA-dependent MCO system, while GSH 
and cysteinyl-glycine did not. 
2. Materials and methods 
I. Introduction 
Thiols are efficient scavengers of reactive oxygen metabo- 
ltes, such as hydrogen peroxide, chlorinated amines or hy- 
t roxyl radicals [1]. The major thiol-containing substance play- 
i lg an essential role in antioxidant defence mechanisms at 
ilflammatory sites is glutathione. Its concentration i the 
l ang epithelial ining fluid of normal nonsmokers amounts 
~9 about 0.4 mM [2]. Subnormal levels of GSH are found in 
hronic inflammations such as idiopathic pulmonary fbrosis 
IL4] or cystic fibrosis [5], which are Characterized by an in- 
~reased oxidant burden [6,7]. Pulmonary glutathione deft- 
iency represents a severe risk for lung tissue injury. Systemic 
. pplication of N-acetylcysteine (NAC) is one promising ap- 
t,roach to support directly the antioxidant capacity or to re- 
plenish GSH levels. This approach is currently evaluated for 
reatment of inflammatory lung diseases with the feature of 
ever GSH-deficiency [8,9]. 
In addition to their protective function against toxic oxygen 
,.adicals, thiols have been shown to enhance DNA oxidation 
10] and lipid peroxidation [11], catalyzed by transition metal 
ons via a thiyl radical (R-S')-dependent mechanism. At phys- 
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2.1. Materials 
GPDH from bovine adrenals (4.6 mg/ml) was from Sigma, Deisen- 
hofen. Stock solutions of GPDH used for the incubation experiments 
were obtained by 1:10 dilution of the enzyme suspension with 20 mM 
potassium phosphate buffer, pH 7.4. Xanthine oxidase (XOD) from 
cow milk (175 mU/mg lyophilisate), superoxide dismutase (SOD) 
from bovine erythrocytes (5000 U/mg) and catalase (CAT) from bo- 
vine liver (65 000 U/nag) were from Boehringer, Mannheim. All other 
chemicals were from Merck, Darmstadt. 
2.2. Inactivation of GPDH by metal-catalyzed oxidation 
Inactivation studies were performed with 0.24 mg/ml GPDH in 20 
mM potassium phosphate buffer, pH 7.4, in a total volume of 0.125 
ml, using two different MCO systems which are specified below. The 
incubations at 37°C were terminated after 30 min by cooling the 
reaction mixtures on ice. Enzyme activity was measured according 
to [19]. The EDTA-dependent MCO system consisted of 0.9 mM 
Fe(II), 3.3 mM H202 and 0.05 mM EDTA resulting in 30-50% in- 
activation of GPDH under standard conditions. In the ADP-depen- 
dent MCO system, EDTA was replaced by 2 mM ADP, resulting in 
50-60% inactivation of the enzyme under standard conditions. To 
study the influence of thiols on basal inactivation by the MCO sys- 
tems, the reaction mixtures additionally contained 0.1, 0.2, 1.0 or 5.0 
mM CYS, NAC, cysteinyl-glycine or GSH. The Fe(II)/H202/EDTA- 
dependent incubations being completed by CYS were carried out in 
the absence and presence of SOD (20 U/ml or 200 U/ml) or BSA (4 
gg/ml or 40 gg/ml). BSA was considered an unspecific radical scaven- 
ger protein. Incubations were made in triplicate, if not otherwise 
stated in Tables 1 and 3. 
2.3. Inactivation of GPDH by xanthine oxidase/hypoxanthine 
Inactivations were performed in0.1 M potassium phosphate buffer, 
pH 7.6, using 0.24 mg/ml GPDH, 6.3 mU/ml XOD, 0.3 mM hypox- 
anthine in the absence and presence of SOD (50 U/ml) or CAT (650 
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U/ml) in a total volume of 0.125 ml. Incubations were carried out for 
30 rain at 37°C and then stopped by cooling the reaction mixtures on 
ice [20]. 
2.4. Analysis of oxidized GPDH for carbonyl content 
Separate incubations with GPDH were performed using the EDTA- 
dependent MCO system to study the influence of CYS (0.1, 0.2 and 5 
mM) on formation of protein carbonyls in parallel to inactivation. 
Conditions of incubation were identical to that described in Section 
2.2. Analysis of protein carbonyl groups has been described elsewhere 
[21,22]. All incubations were made in triplicate. 
3. Results 
3.1. Effect of thiols on GPDH activity in the presence 
of Fe(II), Fe(II)/EDTA, Fe(II)/H202 or 
Fe(II)/H2 02/EDTA 
Enzyme activity after treatment with 0,9 mM Fe(II) in the 
absence of both EDTA and H202 under standard conditions 
amounted to 84.7% of control activity. The remaining activity 
after incubation in the presence of Fe(I I ) /EDTA (0.9/0.05 
mM) or Fe(II)/H202 (0.9/3.3 mM) was 82% or 56%, respec- 
tively. The presence of CYS in both systems did not markedly 
modulate inactivation (Table 1). Similar results were found 
for NAC and GSH (data not shown). 
Treatment of the enzyme with the complete EDTA-depen- 
dent MCO system (Fe( I I ) /H2OJEDTA (0.9/3.3/0.05 raM)) re- 
sulted in a similar inactivation as treatment in the absence of 
EDTA. However, the presence of low concentrations (0.1-1 
raM) of CYS or NAC in this system drastically enhanced 
inactivation of GPDH,  while higher thiol concentrations (5 
mM) were less or not efficient. The additional inactivation 
of GPDH by CYS was prevented by SOD. In contrast to 
CYS or NAC, the presence of cysteinyl-glycine or GSH did 
not promote inactivation by Fe(I I ) /H2OflEDTA (Table 1). 
3.2. Carbonyl content of GPDH after treatment with the 
EDTA-dependent MCO system 
Untreated GPDH contained 0.16 mol carbonyl/mol enzyme 
subunit. Incubation with the EDTA-dependent MCO system 
increased the carbonyl evel to 0.30 mol/mol enzyme subunit. 
A significant carbonyl formation being paralleled by substan- 
tial inactivation was found in the presence of 0.1 or 0.2 mM 
CYS. However, the highest CYS concentration (5 mM) 
caused less carbonyl formation, which was consistent with 
the lower rate of inactivation (Table 2). The increase of car- 
bonyl content from 0.3 to 1.08 mol/mol enzyme subunit by 0.2 
mM CYS was related to 65% loss of activity, suggesting a
rather selective modification reaction at susceptible sites. 
3.3. Effect of CYS on inactivation of G6PDH by 
Fe(II)/H202/ADP (ADP-dependent MCO system) 
Treatment of the enzyme in the presence of Fe(II)/H2Oz 
(0.9/3.3 mM) and increasing concentrations of ADP as chela- 
Table I 
Modulation of Fe(II)/H20~-catalyzed inactivation of GDPH by 
thiols in the presence of EDTA 
Addition Activity in % of control 
(mean -+ S.D.) 
None (control) 100 a 
Fe(II) 84.7 + 11 
Fe(II)/EDTA 82.0 + 18.5 
+0.1 mM CYS 77.7+ 1.50 
+1.0 mM CYS 77.3+5.50 
+5.0 mM CYS 74.7+ 13.6 
Fe(II)/H202 56.0 + 7.5 
+0.2 mM CYS 70.0 + 3.1 
+1.0 mM CYS 57.7+ 12.2 
+2.0 mM CYS 70.3 _+ 8.6 
Fe(II)/H202/EDTA (n = 12) 54.3 + 8.8 
+0.1 mM CYS 14.0+2.0 
+0.2 mM CYS 4.5 + 1.0 
+1.0 mM CYS 4.7_ +1.2 
+5.0 mM CYS 49.3 _+ 5.8 
+1.0 mM CYS +4.0 ~tg SOD 13.0_+ 1.10 
+1.0 mM CYS +40 ~tg SOD 75.6_+ 13.9 
+1.0 mM CYS +4.0 I.tg BSA 5.0_+ 1.9 
+1.0 mM CYS +40 I.tg BSA 8.5_+2.1 
+0.1 mM NAC 7.3_+0.60 
+0.2 mM NAC 3.9 _+ 1.2 
+1.0 mM NAC 5.6_+3.3 
+5.0 mM NAC 51.5+21.9 
+0.2 mM GSH 46.0_+ 8.5 
+0.5 mM GSH 37.0_+4.0 
+5.0 mM GSH 76.0_+ 0
+0.1 mM CYS-GLY 63.5 + 0.70 
+1.0 mM CYS-GLY 62.7 + 7.1 
+5.0 mM CYS-GLY 58.3 + 13.2 
~The activity in the control was 20 + 4 U/ml (mean + S.D.). 
tor (up to 2 mM) resulted in an further loss of activity (data 
not shown). Using 2 mM ADP in the incubations, inactiva- 
tion of GPDH was substantially prevented by CYS, NAC or 
GSH (0.1-5 mM), thus demonstrating a clear scavenger func- 
tion of thiols in the ADP-dependent MCO system (Table 3). 
3.4. Effect of xanthine oxidase/hypoxanthine o  GPDH activity 
Treatment of GPDH with the xanthine oxidase/hypox- 
anthine system caused a substantial inactivation. Depletion 
of enzyme activity was prevented by SOD but not by CAT 
(Table 4), suggesting that superoxide (02"-) is the inactivating 
agent. 
4. Discussion 
Besides the role as the first enzyme in the pentose phosphate 
pathway, mammalian GPDH has a key function in phago- 
cytes by providing NADPH equivalents for the respiratory 
burst oxidase. As recently reported, GPDH is sensitive to 
oxidants arising from metal-driven oxidation systems [17,18]. 
Table 2 
Relationship between formation of carbonyl groups and inactivation of GPDH by Fe(II)/H202/EDTA in the presence of CYS 
Addition Carbonyl content in mol/mol enzyme subunit (mean + S.D.) Activity in % of control (mean + S.D.) 
None (control) 0.16 + 0.03 100 ~ 
Fe(II)/H2OJEDTA 0.30 + 0.12 72.0 + 10.0 
+0.1 mM CYS 0.78 + 0.06 20.0 + 4.0 
+0.2 mM CYS 1.08 + 0.03 7.0 + 4.5 
+5.0 mM CYS 0.45 + 0.03 64.0 + 9.0 
"For GPDH activity in the control, see Table 1. 
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I able 3 
Modulation of Fe(II)/H202-catalyzed inactivation of GDPH by 
(YS, NAC and GSH in the presence of ADP 
Addition Activity in % of control 
(mean + S.D.) 
None (control) 100 ~ 
t e(II)/H2OJADP (n = 9) 41.3 +- 7.2 
+0.2 mM CYS 50.3 _+ 9.0 
+5.0 mM CYS 87.0 +-4.2 
+0.2 mM NAC 74.0_+ 0.0 
+5.0 mM NAC 105.0+-4.0 
+0.2 mM GSH 74.0 _+ 9.9 
+5.0 mM GSH 97.0_+ 25.0 
' For GPDH activity in the control, see Table 1. 
~)xidative inactivation of this enzyme might therefore be a 
~egulatory mechanism to control reactive oxygen metabolite 
l,roduction by phagocytes at acute inflammatory reactions. In 
t ontrast to GPDH from Leuconostoc mesenteroides [23,24], 
the mammalian enzyme contains several cysteine residues 
l~5]. Sulfhydryl groups, however, seem not to be essential 
:or the catalytic activity of the mammalian enzyme as shown 
',y thiol-modifying agents like iodoacetic acid (unpublished 
~iata). This observation is consistent with data recently pub- 
shed,  showing that sulfhydryl oxidation has little effects on 
znetal-catalyzed inactivation of mammalian GPDH [26]. Re- 
markably, the enzyme from Leuconostoc mesenteroides i  
i,ighly susceptible to MCO systems in spite of the absence 
,f cysteine residues [24]. 
In this study, we demonstrated that the presence of low 
, oncentrations of CYS or NAC drastically enhanced inactiva- 
,ion by the EDTA-dependent MCO system. This effect was 
!,revented by SOD (Table 1), suggesting that superoxide 
~O2"-) might play a role in the inactivation process. Super- 
,xide anion generation is thought o result from formation of 
~hiyl radicals (R-S') which are released from the so-called 
epair  reaction (Eq. 1). Thiyl radicals react with thiolates (R 
;-)to give disulfide radical anions (R-SS-R'-; Eq. 2), which 
.re very efficient in reducing 02 to O2"- (Eq. 3), thus increas- 
ng oxidant burden. 
R-SH + A" ~ R-S" ~ AH (A ' - 'OH or R') equation I 
repair reactio~ 
R-S" + R-S" ~ R-SS-R'- equation 2
disulfide radical anion 
R-SS-R'- + 02 ~ R-SS-R + O2"- equation 3
IR-S~R S 
R-S" + O~ ~ R-S-OO" --~ ~ -~ R-SO" equation 4 [27] 
thiylperoxy radical sulfinyl radical 
An alternative mechanism for inactivation is based on the 
eactivity of thiylperoxy (R-S-OO') or sulfinyl radicals 
,R-SO'), which might be generated from R-S" (Eq. 4). 
O,-SO" radicals have been proposed recently to be potent ox- 
dants by abstracting hydrogen atoms from target molecules, 
while R-S" radicals are less potent in causing oxidative dam- 
age [27]. Assuming that this alternative pathway is responsible 
or thiol-mediated inactivation of mammalian GPDH, preven- 
tion of inactivation by SOD could be explained by the possi- 
bility that R-S" radicals are withdrawn from the system via 
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Table 4 
Effect of xanthine oxidase/hypoxanthine (XOD) on GPDH activity 
Addition Activity in % of control (mean + S.D.) 
None (control) 100 a 
XOD (n = 8) 53.8 + 14.3 
+SOD (n=8) 95.5+ 12.5 
+CAT (n=7) 61.7+_9.1 
aFor GPDH activity in the control, see Table l. 
formation of R-SS-R'- radicals (Eq. 2) followed by reduction 
of 02 to 02"- (Eq. 3). In this case, 02" would not be involved 
in inactivation of GPDH, but would represent a sink for toxic 
radicals as proposed by Winterbourn [28]. 
We have provided evidence that treatment of GPDH with 
the XOD/hypoxanthine system inactivates GPDH. This inac- 
tivation is prevented by SOD but not by catalase (Table 4). 
Mfiller et al. [29] recently reported inactNation of mammalian 
GPDH by Oz'-, which is supported by our findings. On the 
basis of these data, we suppose that the CYS-mediated and 
SOD-inhibitable inactivation of GPDH during treatment with 
the EDTA-dependent MCO system is effected by 02"- and 
not by R-S-OO" or R-SO" radicals. 
Analysis of protein carbonyls as an indicator of oxidative 
modification revealed that both the basal inactivation by the 
EDTA-dependent MCO system and the additional inactiva- 
tion by CYS contribute to formation of carbonyl groups in 
mammalian GPDH. The increase of the carbonyl content o 
the maximum level of 1.08 mol/mol enzyme subunit is accom- 
panied by 93% loss of activity, suggesting a site-specific oxi- 
dative modification which is supported by CYS (Table 3). A 
specific amino acid residue in the active site is postulated to be 
susceptible to oxidation. Szweda and Stadtman [24] recently 
found that oxidative inactivation of the bacterial enzyme by 
MCO systems was correlated with the formation of one car- 
bonyl functionality/enzyme subunit, indicating a site-specific 
modification. 
Kim et al. [30] described nonenzymatic cleavage of gluta- 
mine synthetase, another kind of oxidative modification, by 
catalytic amounts of iron salts in the presence of 10 mM 
dithiothreitol. This rather high concentration of thiol appar- 
ently recycles Fe(III) to Fe(II) which then reduces 02 to 02" . 
We have no evidence whether exactly this is relevant in our 
EDTA-dependent inactivation system, which works with 100- 
fold lower concentrations of CYS or NAC. On the other 
hand, we cannot exclude that traces of CYS or NAC specifi- 
cally influence the FE(II)/Fe(III)-redox system, e.g. by forma- 
tion of iron-chelate complexes, which might enhance the ki- 
netics of oxygen reduction to superoxide by the redox system. 
In comparison to the EDTA-dependent MCO system, the 
ADP-dependent oxidation system was different in the re- 
sponse of thiols. ADP and ATP are natural chelators which 
support MCO systems [31,32]. In the ADP-driven system, 
GSH as well as CYS and NAC at low and high concentra- 
tions clearly acted as antioxidants (Table 2). We therefore 
conclude that the nature of the chelator as part of the 
MCO system determines whether a thiol behaves like an anti- 
oxidant or a prooxidant with regard to GPDH as target. So 
far, there is no evidence for the existence of natural chelators, 
which trigger thiols to act as prooxidants against GPDH. 
However, preliminary results on the inactivation of alkaline 
phosphatase by Fe(II) in the absence of both H202 and che- 
lator indicate a prooxidative function of GSH, NAC and 
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CYS. In this case, we assume that the target protein itself may 
be part of the oxidation system, possibly by exhibiting a che- 
lator-like property at the site being attacked. 
In summary, we have shown for the first time that the 
presence of low concentrations of CYS or NAC in a selected 
MCO system mediates oxidative damage to the target protein, 
which is reflected in the introduction of carbonyl groups into 
the target protein and which causes a concomitant loss of 
biological function. Whether related mechanisms might be 
of relevance during antioxidant therapy in treatment of severe 
inflammatory diseases by thiols has to be clarified. 
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